IL11 and neoplasm: It has also been shown that the activation of KRAS increases cytokine levels, such as IL-6 and IL-11 in epithelial cells, which subsequently drives STAT3 activation in an autocrine manner, and that STAT3-triggerd MMP7 is necessary for tumor progression but not for tumor onset, which might be regulated by other STAT3 targets [53].